Inflammatory

Scientists have just discovered a new mechanism that can be key in regulating inflammation in sufferers of autoimmune disease, raising hopes of new drugs that can better protect against it and the ailments it can bring, such as rheumatoid arthritis.

Several new studies are reporting evidence affirming a growing hypothesis that links inflammation with the cognitive deficits seen in bipolar disorder and Alzheimer’s. It's also suggested low-grade inflammation can result in mental sluggishness.

A new metastudy is suggesting anti-inflammatory drugs can reduce symptoms of depression, affirming the long-suspected link between neuroinflammation and depression. However, another study is claiming there is no causal link between the two factors.

Early clinical trial results are suggesting a novel drug designed to inhibit the activity of a key immune signaling molecule could become a promising new treatment for atopic dermatitis, a very common inflammatory skin condition.

New research has for the first time demonstrated how exposure to Narrow Band Ultraviolet B light (UVB) can directly influence gut microbiome diversity in humans. The research hypothesizes this result is modulated by vitamin D.

First results have been revealed from phase 2 human trials into a promising new treatment for celiac disease. The nanoparticle technology was found to significantly induce an immune tolerance to gluten in celiac subjects after just two treatments.

New research has identified a specific genetic variant that may act as a biomarker for patients that are unlikely to respond to new biologic treatments for Crohn's disease.

New research reveals different types of fasting results in significantly different immune responses.

New research demonstrates how a high-fat diet can disrupt levels of an intestinal immune cell known to help regulate microbial populations in the gut. The study shows how low-levels of this molecule result in increased growth of harmful gut bacteria, leading to inflammation and insulin resistance.

A new study is suggesting vibration therapy can beneficially alter the gut microbiome, and reduce diabetes-related inflammation. The research at this point has only been verified in mice, and prior human vibration therapy studies suggest these results may not broadly translate to human treatments.

A team of researchers in Poland has proposed a novel, non-invasive test for screening and monitoring gut diseases such as Crohn’s disease and ulcerative colitis. The technique uses a tiny blood / stool sample to determine gut permeability, a key marker of these diseases.

Research led by the University of Arizona may have uncovered a new potential treatment target for tinnitus – not the ears but within the brain itself. The study suggests that neuroinflammation is to blame, and could be a new way to fix the problem.